MedTrace Logo

An Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 Diabetes

NCT02298556 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2018-03-27

No results posted yet for this study

Summary

To describe the effectiveness of angiotensin-converting enzyme inhibitor and non-dihydropyridine calcium channel blocker single pill combination on systolic blood pressure (SBP) lowering in hypertensive patients with elevated heart rate and type 2 diabetes

Conditions

Sponsors & Collaborators

  • MonitorCRO

    collaborator INDUSTRY

  • Abbott

    lead INDUSTRY

Principal Investigators

  • Enver Atalar, Prof. Dr. · Hacettepe University Faculty of Medicine Hospital Cardiology Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-12-31
Completion
2016-03-08

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02298556 on ClinicalTrials.gov